advertisement

HIV/AIDS

14 August 2013

New drug approved to treat HIV-1

A new drug has been approved by the FDA to treat infection with HIV-1, which is a strain of the virus that causes Aids.

Tivicay (dolutegravir) has been approved by the US Food and Drug Administration to treat infection with HIV-1, a strain of the virus that causes Aids.

The drug's safety and effectiveness were evaluated in clinical studies involving more than 2,500 adults and children, the FDA said. The most common side effects included difficulty sleeping, headache and more serious problems including allergic-like reactions and abnormal liver function in people who had hepatitis B or C.

 

Read Health24’s Comments Policy

Comment on this story
1 comment
Comments have been closed for this article.